相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Mice with human immune system components as in vivo models for infections with human pathogens
Patrick C. Raemer et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Induction of CD8+ T-Cell Responses Against Novel Glioma-Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
Hideho Okada et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Helper Activity of Natural Killer Cells During the Dendritic Cell-mediated Induction of Melanoma-specific Cytotoxic T Cells
Jeffrey L. Wong et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Reconstitution of huPBL-NSG Mice with Donor-Matched Dendritic Cells Enables Antigen-Specific T-cell Activation
Airi Harui et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2011)
Human CD34+ CD133+ Hematopoietic Stem Cells Cultured with Growth Factors Including Angptl5 Efficiently Engraft Adult NOD-SCID Il2rγ-/- (NSG) Mice
Adam C. Drake et al.
PLOS ONE (2011)
Type-I Polarized Dendritic Cells Loaded with Apoptotic Prostate Cancer Cells Are Potent Inducers of CD8+ T cells against Prostate Cancer Cells and Defined Prostate Cancer-Specific Epitopes
Eva Wieckowski et al.
PROSTATE (2011)
Generation of Th1-Polarizing Dendritic Cells Using the TLR7/8 Agonist CL075
Stefani Spranger et al.
JOURNAL OF IMMUNOLOGY (2010)
CD8+T Cell Priming by Dendritic Cell Vaccines Requires Antigen Transfer to Endogenous Antigen Presenting Cells
Alice W. Yewdall et al.
PLOS ONE (2010)
Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines
Adam S. Giermasz et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene
Marie King et al.
CLINICAL IMMUNOLOGY (2008)
Cutaneous gene expression by DNA microarray in murine sclerodermatous craft-versus-host disease, a model for human scleroderma
Lixin Zhou et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice
F Ishikawa et al.
BLOOD (2005)
Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells
G Napolitani et al.
NATURE IMMUNOLOGY (2005)
A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells
G Gautier et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Dendritic cells as therapeutic vaccines against cancer
J Banchereau et al.
NATURE REVIEWS IMMUNOLOGY (2005)
α-type-1 polarized dendritic cells:: A novel immunization tool with optimized CTL-inducing activity
RB Mailliard et al.
CANCER RESEARCH (2004)
The use of dendritic cells in cancer immunotherapy
G Schuler et al.
CURRENT OPINION IN IMMUNOLOGY (2003)
NOD/SCID/γcnull mouse:: an excellent recipient mouse model for engraftment of human cells
M Ito et al.
BLOOD (2002)
The CD68 protein as a potential target for leukaemia-reactive CTL
E Sadovnikova et al.
LEUKEMIA (2002)